This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Post, P. N. Articles by Wakker, P. P. Search for Related Content PubMed PubMed Citation Articles by Post, P. N. Articles by Wakker, P. P. Pubmed/NCBI databases Medline Plus Health Information Neurologic Diseases Stroke Related Collections Health policy and outcome research Behavioral/psychosocial - stroke Resource utilization

(Stroke. 2001;32:1425.)
© 2001 American Heart Association, Inc.

Comments, Opinions, and Reviews

The Utility of Health States After Stroke

A Systematic Review of the Literature

Piet N. Post, MD, PhD; Anne M. Stiggelbout, PhD Peter P. Wakker, PhD

From the Departments of Medical Decision Making (P.N.P., A.M.S., P.P.W.) and Vascular Surgery (P.N.P.), Leiden University Medical Center (Netherlands).

Correspondence to Piet N. Post, MD, PhD, Department of Medical Decision Making, Leiden University Medical Center (K6R), PO Box 9600, 2300 RC Leiden, Netherlands. E-mail P.N.Post{at}lumc.nl

Background—To perform decision analyses that include stroke as one of the possible health states, the utilities of stroke states must be determined. We reviewed the literature to obtain estimates of the utility of stroke and explored the impact of the study population and the elicitation method.

Summary of Review—We searched various databases for articles reporting empirical assessment of utilities. Mean utilities of major stroke (Rankin Scale 4 to 5) and minor stroke (Rankin Scale 2 to 3) were calculated, stratified by study population and elicitation method. Additionally, the modified Rankin Scale was mapped onto the EuroQol classification system. Utilities were obtained from 23 articles. Patients at risk for stroke assigned utilities of 0.26 and 0.55 to major and minor stroke, respectively. Stroke survivors assigned higher utilities to both major (0.41) and minor stroke (0.72). The EuroQol completed by stroke survivors revealed a utility of 0.32 and 0.71 for major and minor stroke, respectively. Utilities elicited by the Standard Gamble were generally higher, while those obtained by the Visual Analogue Scale were lower than the Time Trade Off values. Remaining variation between utilities may be caused by differences in definitions of the health states. The mapped EuroQol indicated a utility of 0.64 for minor stroke and a value just below zero for major stroke.

Conclusions—For minor stroke, a utility between 0.50 and 0.70 seems to be reasonable for both decision analyses and cost-effectiveness studies. The utility of major stroke may range between 0 and 0.30 and may possibly be negative.

Key Words: cost-benefit analysis • decision analysis • outcome • quality of life

This article has been cited by other articles:

				K.-S. Hong and J. L. Saver Quantifying the Value of Stroke Disability Outcomes: WHO Global Burden of Disease Project Disability Weights for Each Level of the Modified Rankin Scale * Supplemental Mathematical Appendix Stroke, December 1, 2009; 40(12): 3828 - 3833. [Abstract] [Full Text] [PDF]

				J. P. Greving, G. J.E. Rinkel, E. Buskens, and A. Algra Cost-effectiveness of preventive treatment of intracranial aneurysms: New data and uncertainties Neurology, July 28, 2009; 73(4): 258 - 265. [Abstract] [Full Text] [PDF]

				D. Arnold, A. Girling, A. Stevens, and R. Lilford Comparison of direct and indirect methods of estimating health state utilities for resource allocation: review and empirical analysis BMJ, July 22, 2009; 339(jul20_3): b2688 - b2688. [Abstract] [Full Text] [PDF]

				M Mangset, E Berge, R Forde, J Nessa, and T B Wyller "Two per cent isn't a lot, but when it comes to death it seems quite a lot anyway": patients' perception of risk and willingness to accept risks associated with thrombolytic drug treatment for acute stroke J. Med. Ethics, January 1, 2009; 35(1): 42 - 46. [Abstract] [Full Text] [PDF]

				U. Alehagen, M. Rahmqvist, T. Paulsson, and L.-A. Levin Quality-adjusted life year weights among elderly patients with heart failure Eur J Heart Fail, October 1, 2008; 10(10): 1033 - 1039. [Abstract] [Full Text] [PDF]

				D. J. McLernon, J. Dillon, and P. T. Donnan Systematic Review: Health-State Utilities in Liver Disease: A Systematic Review Med Decis Making, July 1, 2008; 28(4): 582 - 592. [Abstract] [PDF]

				J. P. Greving, E. Buskens, H. Koffijberg, and A. Algra Cost-Effectiveness of Aspirin Treatment in the Primary Prevention of Cardiovascular Disease Events in Subgroups Based on Age, Gender, and Varying Cardiovascular Risk Circulation, June 3, 2008; 117(22): 2875 - 2883. [Abstract] [Full Text] [PDF]

				M. J.H. Wermer, H. Koffijberg, I. C. van der Schaaf, and For the ASTRA Study Group Effectiveness and costs of screening for aneurysms every 5 years after subarachnoid hemorrhage Neurology, May 27, 2008; 70(22): 2053 - 2062. [Abstract] [Full Text] [PDF]

				H TAKAO, T NOJO, and K OHTOMO Treatment of ruptured intracranial aneurysms: a decision analysis Br. J. Radiol., April 1, 2008; 81(964): 299 - 303. [Abstract] [Full Text] [PDF]

				H. Takao and T. Nojo Treatment of Unruptured Intracranial Aneurysms: Decision and Cost-effectiveness Analysis Radiology, September 1, 2007; 244(3): 755 - 766. [Abstract] [Full Text] [PDF]

				D. A. Regier, R. Sunderji, L. D. Lynd, K. Gin, and C. A. Marra Cost-effectiveness of self-managed versus physician-managed oral anticoagulation therapy. Can. Med. Assoc. J., June 20, 2006; 174(13): 1847 - 1852. [Abstract] [Full Text] [PDF]

				E. Corrado, M. Rizzo, R. Tantillo, I. Muratori, F. Bonura, G. Vitale, and S. Novo Markers of Inflammation and Infection Influence the Outcome of Patients With Baseline Asymptomatic Carotid Lesions: A 5-Year Follow-Up Study Stroke, February 1, 2006; 37(2): 482 - 486. [Abstract] [Full Text] [PDF]

				R. G. Holloway, C. G. Benesch, W. S. Burgin, and J. B. Zentner Prognosis and Decision Making in Severe Stroke JAMA, August 10, 2005; 294(6): 725 - 733. [Abstract] [Full Text] [PDF]

				D. L. Brown, R. D. Chervin, S. L. Hickenbottom, K. M. Langa, and L. B. Morgenstern Screening for Obstructive Sleep Apnea in Stroke Patients: A Cost-Effectiveness Analysis Stroke, June 1, 2005; 36(6): 1291 - 1293. [Abstract] [Full Text] [PDF]

				J. T. King Jr, J. Tsevat, and M. S. Roberts Preference-Based Quality of Life in Patients With Cerebral Aneurysms Stroke, February 1, 2005; 36(2): 303 - 309. [Abstract] [Full Text] [PDF]

				Submacular Surgery Trials Research Group Patients' Perceptions of the Value of Current Vision: Assessment of Preference Values Among Patients With Subfoveal Choroidal Neovascularization--The Submacular Surgery Trials Vision Preference Value Scale: SST Report No. 6 Arch Ophthalmol, December 1, 2004; 122(12): 1856 - 1867. [Abstract] [Full Text] [PDF]

				J. M. Wardlaw, J. Seymour, J. Cairns, S. Keir, S. Lewis, and P. Sandercock Immediate Computed Tomography Scanning of Acute Stroke Is Cost-Effective and Improves Quality of Life Stroke, November 1, 2004; 35(11): 2477 - 2483. [Abstract] [Full Text] [PDF]

				J. W. Sturm, G. A. Donnan, H. M. Dewey, R. A. L. Macdonell, A. K. Gilligan, V. Srikanth, and A. G. Thrift Quality of Life After Stroke: The North East Melbourne Stroke Incidence Study (NEMESIS) Stroke, October 1, 2004; 35(10): 2340 - 2345. [Abstract] [Full Text] [PDF]

				N. F. Col, G. Weber, A. Stiggelbout, J. Chuo, R. D'Agostino, and P. Corso Short-term Menopausal Hormone Therapy for Symptom Relief: An Updated Decision Model Arch Intern Med, August 9, 2004; 164(15): 1634 - 1640. [Abstract] [Full Text] [PDF]

				P. Sandercock, E. Berge, M. Dennis, J. Forbes, P. Hand, J. Kwan, S. Lewis, R. Lindley, A. Neilson, and J. Wardlaw Cost-Effectiveness of Thrombolysis With Recombinant Tissue Plasminogen Activator for Acute Ischemic Stroke Assessed by a Model Based on UK NHS Costs Stroke, June 1, 2004; 35(6): 1490 - 1497. [Abstract] [Full Text] [PDF]

				M. J.H. Wermer, E. Buskens, I. C. van der Schaaf, P. M.M. Bossuyt, and G. J.E. Rinkel Yield of screening for new aneurysms after treatment for subarachnoid hemorrhage Neurology, February 10, 2004; 62(3): 369 - 375. [Abstract] [Full Text] [PDF]

				J. E. Stahl, K. L. Furie, S. Gleason, and G. S. Gazelle Stroke: Effect of Implementing an Evaluation and Treatment Protocol Compliant with NINDS Recommendations Radiology, September 1, 2003; 228(3): 659 - 668. [Abstract] [Full Text] [PDF]

				J. W. Sturm, R. H. Osborne, H. M. Dewey, G. A. Donnan, R. A.L. Macdonell, and A. G. Thrift Brief Comprehensive Quality of Life Assessment After Stroke: The Assessment of Quality of Life Instrument in the North East Melbourne Stroke Incidence Study (NEMESIS) Stroke, December 1, 2002; 33(12): 2888 - 2894. [Abstract] [Full Text] [PDF]

				I. Chakravorty, R.M. Cayton, and A. Szczepura Health utilities in evaluating intervention in the sleep apnoea/hypopnoea syndrome Eur. Respir. J., November 1, 2002; 20(5): 1233 - 1238. [Abstract] [Full Text] [PDF]

				P. N. Post, J. Kievit, J. M. van Baalen, W. B. van den Hout, and J. H. van Bockel Routine Duplex Surveillance Does Not Improve the Outcome After Carotid Endarterectomy: A Decision and Cost Utility Analysis Stroke, March 1, 2002; 33(3): 749 - 755. [Abstract] [Full Text] [PDF]